222 related articles for article (PubMed ID: 20943628)
1. Targeted therapies in soft tissue sarcomas.
Judson I
Ann Oncol; 2010 Oct; 21 Suppl 7():vii277-80. PubMed ID: 20943628
[TBL] [Abstract][Full Text] [Related]
2. Soft tissue sarcomas: are all soft tissue sarcomas treated with the same drugs?
Blay JY; Cassier PA; Ray-Coquard I
Eur J Cancer; 2011 Sep; 47 Suppl 3():S385-8. PubMed ID: 21944026
[No Abstract] [Full Text] [Related]
3. New therapeutic targets in soft tissue sarcoma.
Demicco EG; Maki RG; Lev DC; Lazar AJ
Adv Anat Pathol; 2012 May; 19(3):170-80. PubMed ID: 22498582
[TBL] [Abstract][Full Text] [Related]
4. Targeted agents for sarcoma: is individualized therapy possible in such a diverse tumor type?
Riedel RF
Semin Oncol; 2011 Oct; 38 Suppl 3():S30-42. PubMed ID: 22055970
[TBL] [Abstract][Full Text] [Related]
5. [Targeted therapy of sarcomas].
Cassier PA; Dufresne A; El Sayadi H; Pissaloux D; Alberti L; Decouvelaere AV; Ranchere D; Ray-Coquard I; Blay JY
Bull Cancer; 2008 Oct; 95(10):963-74. PubMed ID: 19004727
[TBL] [Abstract][Full Text] [Related]
6. Dermatofibrosarcoma protuberans and gastrointestinal stromal tumor as models for targeted therapy in soft tissue sarcomas.
Koseła-Paterczyk H; Rutkowski P
Expert Rev Anticancer Ther; 2017 Dec; 17(12):1107-1116. PubMed ID: 28988501
[TBL] [Abstract][Full Text] [Related]
7. Current Molecular Targeted Therapies for Bone and Soft Tissue Sarcomas.
Nakano K; Takahashi S
Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29510588
[TBL] [Abstract][Full Text] [Related]
8. [Targeted therapies in soft-tissue and visceral sarcomas].
Emile JF
Ann Pathol; 2009 Nov; 29 Spec No 1():S81-2. PubMed ID: 19887262
[No Abstract] [Full Text] [Related]
9. [Molecular biology of sarcoma and therapeutic choices].
Dufresne A; Cassier P; Heudel P; Pissaloux D; Wang Q; Blay JY; Ray-Coquard I
Bull Cancer; 2015 Jan; 102(1):6-16. PubMed ID: 25609490
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of AKT-Signaling Sensitizes Soft Tissue Sarcomas (STS) and Gastrointestinal Stromal Tumors (GIST) to Doxorubicin via Targeting of Homology-Mediated DNA Repair.
Boichuk S; Bikinieva F; Nurgatina I; Dunaev P; Valeeva E; Aukhadieva A; Sabirov A; Galembikova A
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33266502
[TBL] [Abstract][Full Text] [Related]
11. Histology-Specific Uses of Tyrosine Kinase Inhibitors in Non-gastrointestinal Stromal Tumor Sarcomas.
Sethi TK; Keedy VL
Curr Treat Options Oncol; 2016 Feb; 17(2):11. PubMed ID: 26931561
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic pipeline for soft-tissue sarcoma.
Cassier PA; Labidi-Galy SI; Heudel P; Dutour A; Méeus P; Chelghoum M; Alberti L; Ray-Coquard I; Blay JY
Expert Opin Pharmacother; 2011 Nov; 12(16):2479-91. PubMed ID: 21913865
[TBL] [Abstract][Full Text] [Related]
13. Notch pathway inhibition with LY3039478 in soft tissue sarcoma and gastrointestinal stromal tumours.
Mir O; Azaro A; Merchan J; Chugh R; Trent J; Rodon J; Ohnmacht U; Diener JT; Smith C; Yuen E; Oakley GJ; Le Cesne A; Soria JC; Benhadji KA; Massard C
Eur J Cancer; 2018 Nov; 103():88-97. PubMed ID: 30218977
[TBL] [Abstract][Full Text] [Related]
14. Targeted therapy in bone and soft tissue sarcoma in children and adolescents.
Thompson PA; Chintagumpala M
Curr Oncol Rep; 2012 Apr; 14(2):197-205. PubMed ID: 22302601
[TBL] [Abstract][Full Text] [Related]
15. Targeted Chemotherapy in Bone and Soft-Tissue Sarcoma.
Harwood JL; Alexander JH; Mayerson JL; Scharschmidt TJ
Orthop Clin North Am; 2015 Oct; 46(4):587-608. PubMed ID: 26410647
[TBL] [Abstract][Full Text] [Related]
16. The past, present, and future of cytotoxic chemotherapy and pathway-directed targeted agents for soft tissue sarcoma.
Ryan CW; Desai J
Am Soc Clin Oncol Educ Book; 2013; ():. PubMed ID: 23714556
[TBL] [Abstract][Full Text] [Related]
17. Fibroblast Growth Factor Receptor (FGFR) Signaling in GIST and Soft Tissue Sarcomas.
Napolitano A; Ostler AE; Jones RL; Huang PH
Cells; 2021 Jun; 10(6):. PubMed ID: 34204560
[TBL] [Abstract][Full Text] [Related]
18. Precision Oncology in Soft Tissue Sarcomas and Gastrointestinal Stromal Tumors.
Fontebasso AM; Rytlewski JD; Blay JY; Gladdy RA; Wilky BA
Surg Oncol Clin N Am; 2024 Apr; 33(2):387-408. PubMed ID: 38401916
[TBL] [Abstract][Full Text] [Related]
19. Role of new chemotherapy agents in soft tissue sarcoma.
von Mehren M
J Natl Compr Canc Netw; 2005 Mar; 3(2):198-205. PubMed ID: 19817029
[TBL] [Abstract][Full Text] [Related]
20. Emerging drugs for the treatment of soft tissue sarcomas.
Cassier PA; Dufresne A; Fayette J; Alberti L; Ranchere D; Ray-Coquard I; Blay JY
Expert Opin Emerg Drugs; 2007 Mar; 12(1):139-53. PubMed ID: 17355219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
